I'm (somewhat) surprised to not see DeGray or his SENS mentioned in the article or the discussion. I thought he and his approach gradually moved from the area o

I'm (somewhat) surprised to not see DeGray or his SENS mentioned in the article or the discussion. I thought he and his approach gradually moved from the area of crazy science to (at least) one of the approaches attracting attention from some more mainstream researchers? After all the "Hallmarks of Aging" (2013), more or less mainstream research article published in "Cell", looked at the aging process from a similar perspective. If I understand correctly, at least one of SENS components - namely, AmyloSENS - is currently being targeted by a number of biotech startups, looking into use of senolytic drugs to clear up senescent cells. DeGray himself is currently attempting a Robust Mouse Rejuvenation however from what I understand the results from trial 1 were more than modest, if not to say disappointing.